Advertise on HotCopper. SUBMISSION STEPS. podcasts, and hotcopper) Reading announcements from Starpharma and having to decipher what is actually being said And finally, lacking the ability to sell our products currently. 971M ! Add to my watchlist. Hey, "smart", I concur with your message. Can anybody load up the most recent Bell Potter Analysis on SPL? I am unable to source it thanks. Dec 14 (Reuters) - Starpharma Holdings Ltd (SPL) : VIRALEZE NASAL SPRAY REGISTERED IN INDONESIA PROGRESSING DISCUSSIONS WITH POTENTIAL DISTRIBUTION. 57% 13. Maybe SPL is frustrated at the lack of promotion, or maybe they have frustrated McKesson with continuity of supply, but I doubt it this early in the relationship - the logistics will be guided by demand, and it takes time to find the right equilibrium without overcommitting funds and/or scaling up manufacturing capacity, honouring contracts etc. Created with Sketch. Market Cap $57. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. ASX - By Stock. And somebody must be buying all the shares that are being sold. Starpharma is a world leader in the development of new medical products based on its proprietary dendrimer technology and has partnerships with leading global companies, including AstraZeneca, MSD (Merck & Co. ASX - By Stock. Created with Sketch. Latest Posts. Latest Posts. I think that the more time that passes without profits, the less likely that there will ever be profits. To be fair the ASX has made tries on 3 recent contracts to squeeze information from SPL when didn’t want to disclose how immaterial the contracts is. 0¢. Only 12 episodes made but so Iconic . 72. 11%. However, just a word of caution before the usual pumping starts by the usual suspects. . We know that they haven't been marketed well but i think BigPharma have had an input. Feb 28 (Reuters) - Starpharma Holdings Ltd (SPL) : HY REVENUE FROM CONTINUING OPERATIONS DOWN 16% TO A$1. IMO the Starpharma HQ kool-aide would be tasting pretty bitter these days. 56% 14. AZ will be watching Phase 2 results and assessing the market against the potential SPL bill. Starpharma is listed on the Australian stock exchange (ASX:SPL). I wonder if LLoyds are taking the pain on 50% off or if SPL rebating just to get volume and name in market ? LLoyds depending on agreemnet would usually just return stock IMO. SPL. Last updated 15. 2:00 am Eastern Standard Time Australia. SPL Price at posting: 14. It knows of Viraleze - so its rationale for letting Viraleze meander through regulatory processes with no due haste or intervention is mystifying. Created with Sketch. 6% (1. Join the HotCopper ASX share market forum today for free. Forums. More. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Hope that SPL starts to deliver on its promises. Charts. . Please type the title in sentence case (that is lowercase with only the first letter or the first word in capitals) and without any punctuation. I averaged down over the next year and the lowest point I bought was at 57c. . 56am 20/11/2023 ? HotCopper has news, discussion, prices and market data on MAGNIS ENERGY TECHNOLOGIES LTD. $0. . Charts. “Who in at SPL made these commitments on timelines?” ~ @Joelsmith2452 CEO Jackie Fairley first told shareholders that the current Phase 2 DEP-Docetaxel trial would be complete by the end of CY2018. 8985. ASX - By Stock. Last edited by antibotter : 13/11/23. 1. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. . The thread is titled so that it can be found and general enough so as to. Its a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. Created with Sketch. The sycophants, pompom-wavers, management apologists, cheerleaders and perennial uprampers of SPL on a Hotcopper know who they are. Interesting write-up. No China virus, no Flu, no colds. Market . Market . . Join the HotCopper ASX share market forum today for free. Click for more information. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Click for more information. RDN Raiden Resources secures complete control of lithium at Arrow Project, buys out Arrow Minerals Ltd. 55pm 17/11/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. ASX - Day Trading. Hey, "smart", I concur with your message. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 59pm 20/11/2023 ? HotCopper has news, discussion, prices and market data on MESOBLAST LIMITED. - 12:30 p. also not sure why anyone should get excited about a daily decrease in the short position of 0. . SPL polylycine dendrimers are proving to play a major role in the future of ADC’s. Eight (8) contributors to the HC SPL thread made price predictions (thank. Starpharma AGM Summary (Part 1) Oh. . ASX - Day TradingCurrent SPL CEO setting a pretty high bar here, especially in light of the less than sparkling track record. Below are 3 charts showing the predictions for Starpharma's Price by End 2019. 70. $-0. VivaGel BV/Fleurstat was for many years touted as being a company maker in it’s own right. Created with Sketch. * All the touted pending/expected deals with the Majors come to very little with the usual statement "in discussions"Created with Sketch. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. 0000. Or primary care stop like a medical centre or clinic- stating the obvious- hope SPL have better marketers than I) Also would like to see what the USA have done to allow retail investor to get involved in per IPO rather than just institutions investors getting the huge discount to Share Price. 9¢. . Commodities. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . We love cruising, but this multi billion dollar industry has effectively been shut down. Some links within this article worth a scan too. $0. ASX - Day Trading SUBMISSION STEPS. HotCopper has news, discussion, prices and market data on SPLITIT PAYMENTS LTD. 82%)And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Magnum Mining and Exploration Limited is an Australia-based company (ASX: MGU), which is engaged in mineral exploration and project development in Nevada, US. Let's not forget that this happened due to the poor performance of management that contributed to SPL getting the boot from. I'd think that SPL will be covering all the bases required for a crack at 505b2, but with the necessary data to pivot to a phase 3 trial if. 58pm 20/10/2023 ? HotCopper has news, discussion, prices and market data on STARPHARMA HOLDINGS LIMITED. The goal of the partnership. ASX - Short Term Trading. Created with Sketch. Latest Posts. ASX - By Stock. Created with Sketch. . Hotcopper has reinvented itself as The Market Herald with an ASX code of TMH The company has an online news site called The Market Herald Below is a. Advertise on HotCopper. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. 16,364,160. 4. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Charts. The results will be good but will they be good enough for SPL to be able to do the deals. . ASX - Day Trading Last day Spl remains in ASX300 Institutions and/or shorters buying TIME LINE At auction today there were 20 million shares wanted to buy and 11 millions shares wanted to sell Notice after close of auction there were still 10 million shares wanted to buy and 450k to sell Merck has tightened its ties to Starpharma as it continues to build out its antibody-drug conjugate (ADC) capabilities, signing a second agreement that will enable it to evaluate candidates based. Target our investor community with our suite of Hotcopper Advertising opportunities. The CEO chose to drop a throwaway line at the end of her presentation to potential investors as reported by Antibotter ie “ Starpharma are pursuing registration in China for Viraleze “ as one of if not the biggest market in the world one would think this is a price sensitive comment after all it was said as bait to potential investors. Just wondering if anyone else took the time to report Starpharma to the ASX as I did? Remember, NOTHING will ever change if CEOs and Directors of public. 32 , that is a daily rise of over 50% on the market capital at the time it hit that low. Talk with one of our capital market experts to learn more about our innovative and. SPL have put a lot of time and energy into Docetaxel and Cabazitaxel over many years but it is Irinotecan that seems to be wining the race, probably benefiting from the accrued knowledge from the Doc and Cab trials. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). HotCopper has news, discussion, prices and market data on TRIGG MINERALS LIMITED. Below are 3 charts showing the predictions for Starpharma's Price by End 2019. Created with Sketch. Above $20m revenue, SPL rakes in zero R&D tax refunds until revenue becomes high enough for SPL to actually make a profit. Announcement on LinkedIn today from Prof David Owen that has left SPL after 15years as VP. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. 43M. Offers an alternative as reasons for delays, been at the mercy of regulators playing catch-up somewhat. So much coming up with Viraleze and DEP Starpharma team will be working very hard at the moment with so many balls in the air. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. Your missing the signals guys/gals looking too much at Viraleze, other products, CEO, BOD etc, read the signals my friend's there is a major DEP Move in. 5 cents. . 48. Join the HotCopper ASX share market forum today for free. Market Cap $5. ASX - Short Term Trading. Think SPL has a valuation of 500mil…based on potential, or just promise. 75802. One of those is worse that SPL. NEVER - there should be an official corruption enquiry considering the Gov Funding and R&D reimbursements recieved by SPL and what actually was achieved and why they haven't been succesful - there's US companies flogging Povidine Iodine nasal spray and throat sprays left right and centre. 2663916. . However, the interim results from ongoing Phase One NCT04865419 (the most advanced trial) was a little underwhelming IMO. 5¢. Created with Sketch. Created with Sketch. Created with Sketch. 8¢. ,), Okamoto, LifeStyles, Aspen and Mundipharma. SPL is tanking, HQ are overpromising and under delivering. ASX - General. ASX - Day TradingSo ton of quistions to answer for CEO and Board most of them already posed so does she follow past format by putting out an update today that she can. 50 peak) that they hadn’t missed the boat and that SPL was soon going to $3. Market . That won’t be a shock to. Perhaps they will today tomorrow. . ASX - Day Trading. 3¢. Created with Sketch. Stay informed on the day’s latest market trends and receive exclusive access to HotCopper’s trending analysis with inside stories from TMH to help you make sense of what’s happened and navigate what’s ahead. . Latest Posts. Follow your favourite stocks, view charts, track. Volume. ASX - By Stock. 52 (16th Feb) on the back of the hype that surrounded the launch of VIRALEZE in UK/EU/WORLD. 49M. HotCopper is Australia's largest free and independent stock market trading forum for. 22%) 3,361,416 was the lowest point of total short sales for some years as of 15/06/23 (0. ”For your information 55% of the company is held by institutions” ~ AB I. 24am 31/10/2023 ? Share Prices & Charts for STARPHARMA HOLDINGS LIMITED. Follow your favourite stocks, view charts, track gainers and losers and discuss topics including politics, commodities, cryptocurrency and managed funds. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . , page-2. 1. Latest Posts. . 63M. DJPIN. Eight (8) contributors to the HC SPL thread made price predictions (thank. The only double standard I see is that if any employee in the real world repeatedly told their boss that a project would definitely be delivered, every year since 2018 and the project has still not been delivered in early 2023 then they would be ceremoniously SACKED. yet if one considers that the amount of millions of shares via option they. ASX - Day TradingDoes Spl deserve to be seven times less in mkt cap to another biotech that has one phase 2 product spl potentially 3 and commercialisation deal with astra zeneca and collaboration deals with Merck and Genentech. ASX - By Stock. ASX - By Stock. Fortescue Metals Group Ltd (Fortescue) is an Australia-based company engaged in iron ore. . Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Comments. ASX - By Stock. ASX - Short Term Trading. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . Well done SPL and Scripps Institute. ASX - General. Latest Posts. Ineffective deals and sloppy clinical trials and regulatory tactics might be able to be gloss over for years but over times it show in the bottom line. 00%. 5¢. Hey, "smart", I concur with your message. I recall reading your postings (largely optimistic, I think) about SPL when I first stumbled onto this site years ago. Become a member of Australia's largest investment discussion forum. IMO they haven't . 0¢. 37. And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . SPL's current SP is about 15 cents, after many years (some say 20 years) of unprofitability, during which time substantial salaries and performance bonuses appear to have been paid. Forums. Anyways, after nearly 20 years in SPL, I have broken every investment rule and plunged in last week to top up and reduce my average entry cost. 0¢. . Last updated 15. Quarterly Activities Report & Appendix 4CLooking further into the AGM notice, Resolution 3 is a massive slap in the face to share holders!!!Basically the company is proposing to dish out a bonus. Although with SPL's track record an exceptionally good news announcement seems unlikely, it is within the realms of possibility - and this seems to be what makes SPL worth a gamble. 2327/7/2021 CSL $292. All that seems to happen is that new verses are sometimes added. ASX - General. SPL Price at posting: 49. Do they actually work day in day out? Do research everyday? If so why after 20 years we are still at phase 1/2. Deliver ZERO dividends, a NEGATIVE capital return and depressed share price to shareholders over a 17 year period. Market. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. Last edited by sarge17: 28/11/22. SPL always has tantalising carrots to dangle before the eyes of investors. Created with Sketch. Created with Sketch. Created with Sketch. A halleluljah announcement just days before the AGM would imo be proof that investors in SPL have for years been treated like mugs. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Join the. Target our investor community with our suite of Hotcopper Advertising. Target our investor community with our suite of Hotcopper. Canadian Dollar. ASX - Short Term Trading. With EOFY selling about to hit us like a freight train, where does everyone think the bottom will be for SPL' shareprice?Unless one of the many promises. Even if these collaborations have beenterminated, the market deserves to know about it. Views. I can't guess where or what or when, perhaps there is an informed opinion out there in HC SPL land but we have a very tight market and some. , page-3. ASX - By Stock. 26. 38. , Inc. . $0. Last updated 15. 0 Great. But the products were developed as proof of a saleable dendrimer product. I am closely watching the state of the World Economy, particularly China and the U. 0¢. SPL Price at posting: 16. Share WOW! Exactly 2 years after the start of this trial and still: NONE OF THE PATIENTS MET THE FORMAL CRITERIA OF A RESPONSE This is according to AstraZeneca’s own data, which is exactly the same disappointing result they announced in the last update last year at the ASHA congress in the USA in Dec 2022. Hi all, I think it would be in all of our best interests if each of us sent an email to SPL investor relations and voiced our concerns. ASX - Day TradingTime to top up again for me What about youBetween Oct 2017 and Mar 2018 it seemed like we held pretty consistently above $1. To make matters worse he has AZD0466 on hold through no fault of the dendrimer technology, which appears to be highly successful in dealing with the drugs toxicity. 3¢ STARPHARMA HOLDINGS LIMITED - Discussion. Right size, can penetrate deep into tumour tissue, right architecture, hang around long enough to do the job, soluble so the. Join the HotCopper ASX share market forum today for free. ASX - Day TradingThe short position has been negligible in Starpharma since we go booted from the ASX300 and the shorts were able to cover a large portion of their position at rock bottom share prices in the re-balance. Forums. Market . Volume. 13. ASX - Day TradingI will just put it out there that I have been peeved off about our CEO Jackie Fairley and the performance of SPL for a while now. . It was fairly obvious to the market that a crap raise was coming, and the SP might rise on this last chance in a while being out of the way before SPL is well capitalised. 0¢ Sentiment: Buy. . . ASX - General. 3¢. ASX - By Stock. I visited their offices in Melbourne near the Alfred a few times and thought they were on to some pretty neat tech. As to finding the bottom, a milestone of sorts was reached today for SPHRY (the ADR on the US market equivalent to 10 SPL shares). Firstly, I’m a big fan of SPL and proud of all of their achievements to date (even picked up a few more shares the other day). 5¢ STARPHARMA HOLDINGS LIMITED - Discussion. Gumnut, first class summary and analysis! In the end, basic fundamentals will rule the day re the success or otherwise of SPL - our orphaned dendrimer technology company. 1029/9/2000 SPL $0. And that is my opinion too but about SPL. ASX - General. Charts. Share Interesting and positive early pre-clinical results. Join the HotCopper ASX share market forum today for free. Notification of cessation of securities - SPL. If only SPL management would undertake Human Trials for Viraleze ? The experts are leaning towards more nasal spray use including as vaccines but our management are too busy organising their free shares. 5230. Time flies. SPL Price at posting: 44. Is this a case of short memories? The best one can say is her surprise is disingenuous. GLTAH but for me SPL is still a strong AVOID until a development of substance is announced. The recent announcement about Viraleze nasal. 367026. Market . Is the board simply resting on their collective (pre spl) laurels?Just in case you missed it HEALTHCARE Starpharma (SPL) Strong results from first in man Phase 1 DEP Docetaxel trial validate SPL’s DEP platform Safety. 5¢. Join the HotCopper ASX share market forum today for free. Enter the title of your abstract. The usual suspects on Hotcopper were pumping the Hong Kong and Macau ’deal’ last year as a game changer and rivers of gold were going to flow across the border from China for Viraleze, apparently. 00%. Market . And SPL still cannot generate enough revenue to even break even! Expand While the current management may be very astute at carrying out research and developing potentially great drug/drug platforms, they ARE NOT showing any signs of success when it comes to commercialisation of these products . In SPL's case there is clearly another. m. Melbourne, Australia; 16 March 2021: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that its second radiopharmaceutical candidate, DEP® HER2-lutetium, achieved potent and durable anticancer activity, with complete tumour regression, outperforming Herceptin® (trastuzumab) labelled with lutetium, in a human breast cancer. Created with Sketch. Then you have the obvious issues with distribution with Lloydsand possiblly really cheap deal with Vietnam let alone teh mysterious India ,. Latest Posts. Share Step 1. 578296. ASX - General. Share Interesting points John Some institutions might accept anything over $1. Nope. See All Discussions. Hi FolksIts a boring market today and I had time to revisit SPL, where I am a long, long time weary holder. My last 350 posts take me back over two years and cover about twenty different stocks. 8%. It seems long-suffering retail. 2. DYOR Why am am I still positive well let's go through my path to here in 2016/17/18 I was buying shares I bought one package of 100,000 for 66 cents and ended. It is now more than ever that SPL needs to communicate with the market and keep everyone informed of any updates, because the radio silence and smoke and mirrors approach is evidently NOT WORKING. 70. Dr. 9¢. ASX - By Stock. Merck will fund the research, although Starpharma doesn’t expect the fees to be material, and. Created with Sketch. Expanding claims in UK- hmmm it would be a gamble by SPL to choose to put up that option rather than continue as is as MHRA may have same questions TGA has got ( whatever exactly they are) that don't seem to be. Everyone holding SPL shares should now realise that unless they can have a deal signed on at least one of the Dep candidates within 3 to 6 months with a substantial. Last updated 15. SPL has on multipleoccasions used COVID as an excuse for expanded timelines on active trails andto my understanding SPL has also been receiving support from the governmentduring COVID. More. 53pm 22/11/2023 ? HotCopper has news, discussion, prices and market data on SUNRISE ENERGY METALS LIMITED. My theory is we had a large accumulator that was content buying. Last updated 15. A correctly formatted example follows: Title of my presentation for the conference. ASX - By Stock. Target our investor community with our suite of Hotcopper Advertising opportunities. Investors and the ASX now have their eye on SPL like they normally would have on dodgy mining penny stocks. Join the HotCopper ASX share market forum today for free. . News: SPO Spotless Group To Be Removed From Official List Of ASX Ltd At Close Of Trading On 30 Aug. ASX - By Stock. SPL conducts a "trial" (use that word loosely) in of all places WA !! Yet our commercial hotshots cannot arrange a deal with a WA based company who appear highly capable and connected in getting distribution to sought after sectors like "Allied Health practitioners, the corporate sector and government". .